Evidence map›Paper›PMID 39550225›Full record

ArticleBriefings in bioinformatics2024

MPA-MutPred: a novel strategy for accurately predicting the binding affinity change upon mutation in membrane protein complexes.

Fathima Ridha, M Michael Gromiha

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fathima RidhaDepartment of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, India.
M Michael GromihaDepartment of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, India.ORCID 0000-0002-1776-4096

Funding

DBT, India BT/PR40237/BTIS/137/79/2023Ministry of Education, India
6 · The paper itself

Abstract

Mutations in the interface of membrane protein (MP) complexes are key contributors to a broad spectrum of human diseases, primarily due to changes in their binding affinities. While various methods exist for predicting the mutation-induced changes in binding affinity (ΔΔG) in protein-protein complexes, none are specific to MP complexes. This study proposes a novel strategy for ΔΔG prediction in MP complexes, which combines linear and nonlinear models, to obtain a more robust model with improved prediction accuracy. We used multiple linear regression to extract informative features that influence the binding affinity in MP complexes, which included changes in the stability of the complex, conservation score, electrostatic interaction, relatively accessible surface area, and interface contacts. Further, using gradient boosting regressor on the selected features, we developed MPA-MutPred, a novel method specific for predicting the ΔΔG of membrane protein-protein complexes, and it is freely accessible at https://web.iitm.ac.in/bioinfo2/MPA-MutPred/. Our method achieved a correlation of 0.75 and a mean absolute error (MAE) of 0.73 kcal/mol in the jack-knife test conducted on a dataset of 770 mutants. We further validated the method using a blind test set of 86 mutations, obtaining a correlation of 0.85 and an MAE of 0.77 kcal/mol. We anticipate that this method can be used for large-scale studies to understand the influence of binding affinity change on disease-causing mutations in MP complexes, thereby aiding in the understanding of disease mechanisms and the identification of potential therapeutic targets.

Indexed as

Membrane ProteinsMutationProtein BindingAlgorithmsComputational BiologyHumansSoftwareMembrane Proteinsbinding affinity changemembrane proteinsmutationsequence-based featuresstructure-based features

Identifiers

PMID39550225
PMCPMC11568875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.